The sarcoplasmic reticulum was isolated and characterized in the pure form from normal caprine (Capra hircus) hearts. Under ischemic condition, fatty acids like palmitic acid, palmitoyl carnitine and oleic acid accumulate in vivo. These are known to have a detrimental effect on membrane components. The effects of simulated ischemia on the Ca 2+ -ATPase were studied using these fatty acids in vitro at concentrations at which they occur in vivo in the ischemic heart. All three fatty acids inhibited Ca 2+ -ATPase activity. At lower concentrations, palmitoyl carnitine was the most potent, followed by oleic acid while palmitic acid displayed the least potency. Electron microscopy studies with fatty acids showed morphological disruptions in SR vesicles. The decline in Ca 2+ -ATPase activity could be attributed to the change in membrane morphology.
The combined effect of lipid abnormalities finally contributes to a decline in myocardial contractility; the arrhythmias and eventual cell death that follow coronary artery occlusion ensue. Lipid abnormalities have been firmly established as a major factor leading to ischemic heart disease since the past couple of decades. Fatty acids are released from ischemic cardiac muscle due to activation of phospholipase A2 (5) . Fatty acid accumulation in concentrations above normal is a hallmark of ischemia. Their effect interferes with the normal function of the heart and the SR in particular. Palmitic acid causes a reduction in the phospholipid content of SR membranes as observed from freeze fracture electron micrographs. In increasing concentrations, palmitic acid causes the SR membranes to undergo fusion with eventual breakdown of their vesicular structure. Palmitoyl carnitine produces marked changes in the structure and function of the sarcoplasmic reticulum and, at increasing concentrations, is believed to inhibit key membrane-bound enzymes, the most important being the marker enzyme Ca 2+ -ATPase (6) . Oleic acid, by disrupting the morphology of the membrane vesicles, causes permeability changes leading to the inhibition of ATP-induced calcium sequestration, in effect altering the activity of the marker enzyme Ca 2+ -ATPase (7) .
INTRODUCTION
The heart prefers fatty acids over carbohydrates and proteins as oxidisable substrates, mitochondrial oxidation accounting for about 60-70% of the total amount of ATP required by the heart (1). Under normal physiological conditions this preference is adequately satisfied. However, under ischemic conditions, a lack of blood supply deprives the heart of oxygen limiting the availability of the same for oxidative phosphorylation; fatty acid and carbohydrate oxidation decline and ATP production is impaired. A series of metabolic failures ensues (2, 3) . As a result, free fatty acids in the ischemic heart increase almost six to seven fold (4).
Cardiac function is influenced by changes in lipid composition of the cellular and subcellular membranes of myocardial cells. A modification in structure of cardiac membranes could produce significant abnormalities in cardiac function viz. mobility and conformation of intrinsic membrane proteins (3).
ischemia is a condition wherein the cellular and subcellular environment is reproduced in vitro to study the debilitating effects of several metabolites on isolated membranes, cells and their components. The goal of the present study is to establish a correlation between ischemia and the degree of impairment of the enzyme Ca 2+ -ATPase in vitro.
MATERIALS AND METHODS
The SR was isolated from the heart by a modified method of Feher and Davis, 1991 (8) .
SDS-PAGE -Individual aliquots of 50Pl of the SR sample containing 50-60mg were treated with 5PM, 20PM and 50PM palmitic acid (PA); 10PM, 20PM and 40PM palmitoyl carnitine (PC); 6PM, 12PM and 16PM oleic acid (OA) were run on a 10 % SDS polyacrylamide gel. One untreated aliquot was maintained as the control. 50mg pre-treated SR samples were loaded per well. Wide range molecular weight marker from Sigma and BSA -Fraction V (Sigma) were used as standards.
Enzyme Assays -Individual aliquots of 50Pl of the SR sample containing 50-60mg were treated with 5PM, 10PM, 20PM and 50PM palmitic acid (PA); 5PM, 10PM, 20PM, 40PM and 60PM palmitoyl carnitine (PC); 6PM, 12PM and 16PM oleic acid (OA) individually for 20 minutes at 37°C. One untreated aliquot was maintained as the control. Ca 2+ -ATPase activity (SR marker enzyme) was determined for both 'untreated' and 'treated' SR aliquots at 37°C by measuring P i production (9) .
Electron Microscopy -PA, PC and OA were added individually to nine separate tubes of 30Pl Buffer marked 'PA-5PM ', 'PA-20PM ', 'PA-50PM ', 'PC-20PM', 'PC-40PM', 'PC-60PM', and 'OA-06PM', 'OA-12PM', 'OA-16PM ' respectively in concentrations as specified on each tube. The tubes were incubated at 25°C for a period of 20 minutes. The suspension was then centrifuged at 25,000 rpm in an SW 40 swing out rotor for 30 minutes. The pellet obtained was dispensed in glutaraldehyde solution and stored at 4°C for a maximum of 2 hours prior to further treatment for EM viewing. SR samples for thin sections were fixed in cold 3% glutaraldehyde solution for 2hours and treated with osmium tetroxide. After dehydration and embedding, thick sections were cut on an LKB Ultratome V, dried on a hot plate (60°C), stained with 1% toluidine blue and observed under the light microscope. The prepared blocks were trimmed, ultrasections cut and placed on 300 mesh size copper grids. Contrast was enhanced by a double staining technique -alcoholic uranyl acetate and lead citrate. Grids were observed under a JEOL -1010 electron microscope at 80kV accelerating voltage.
RESULTS AND DISCUSSION
There was no change in the banding pattern or the intensity of the component proteins of fatty acid treated SR samples when compared with the normal control SR. In this study we observed that addition of palmitic acid, at concentrations of 5PM, 10PM, 20PM and 50PM, to SR preparations, caused a significant reduction in SR Ca 2+ -ATPase activity. The activity declined further with an increase in PA concentration [Table  IV] . Similarly, palmitoyl carnitine and oleic acid caused a decline in Ca 2+ -ATPase activity [ Table V , VI]. 5PM resulted in 21% loss of activity while 10PM and 20PM palmitic acid reduced Ca 2+ -ATPase activity by 33% and 32% respectively. 50PM yielded a loss of 65% enzyme activity [ Table I ]. 5PM palmitoyl carnitine resulted in a 40% decrease in enzyme activity. There was a 54% decline seen at 10PM, a 45% drop in activity was seen at 20PM and a 72% loss of activity at 40PM and 60PM each [ Table II] . Oleic Acid at a concentration of 6mM inhibits enzyme activity by 32% and at 12PM the enzyme activity declines by 63%. 16PM showed a decline of 72% [ Table III ]. The Student's Paired t-Test has been employed to determine the statistical significance of the effect of fatty acids on the SR Ca 2+ -ATPase. The enzyme activity was compared as the average difference between individual fatty acid-treated groups and normal (untreated) groups. Correlating the spectrophotometric analysis of Ca 2+ ATPase to the results of SDS-PAGE, we obtained a direct confirmation that the decline in ATPase activity is not due to any loss of Ca 2+ -ATPase pump units but due to a structural change in the lipid bilayer. The altered lipid environment prevents the pump from functioning optimally.
Incubation of the SR with the straight chain C16 saturated fatty acid palmitic acid caused the activity of Ca 2+ -ATPase The sudden decline in activity shows that, unlike palmitic acid, the effects of this fatty acid are not gradual. Inhibition of Ca 2+ -ATPase activity by the unsaturated fatty acid oleic acid in the range of 6-12PM was seen to be directly proportional to the concentration of oleic acid.
Our isolated SR samples treated with palmitic acid showed different structural alterations depending on the concentration of the fatty acid. At 5PM, there was no change in the structure of the vesicle as compared with the electron micrographs of normal SR (figure 1). A fusion of vesicles was seen at 20PM 
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Simulated Ischemia and Sarcoplasmic Reticulum while the fusion was more pronounced at 50PM (figure 2). Hence the drop in activity at low concentrations (5PM) is a result of two factors: (a) formation of calcium-palmitate aggregates (5) due to negatively charged palmitic acid at or near the surface of the phospholipid bilayer and (b) its incorporation into the bilayer without altering the spatial arrangement of the phospholipids. These conditions would result in the negatively charged palmitic acid forming a calcium pool independently and blocking both the availability of calcium to the ATPase pump and its subsequent infiltration into the SR lumen (12) . There is also a possibility of palmitic acid interacting directly with the active site of the enzyme (10) . Other studies show a fusion of vesicles at 20PM resulting in a loss of phospholipid bilayer structure hence loss of fluidity and subsequent breakdown of the microenvironment suited to optimal ATPase activity (6) . Electron micrographs of SR samples treated with palmitic acid in the range of 20-50PM show a loss of bilayer vesicular structure. Our study indicates a direct effect of palmitic acid at >20PM on the enzyme conformational structure resulting in a partial loss of activity. This deprives the ATPase enzyme of the suitable phospholipid environment necessary for its function (seen as a decline in activity).
Long chain acyl carnitines (LCAC) are amphipathic in nature allowing them to get incorporated into membranes and disrupt the phospholipid bilayer with subsequent functional alterations of membrane proteins (11) . From our electron micrographs of SR vesicles treated with varying concentrations of palmitoyl carnitine (figure 3), we observed an incorporation of palmitoyl carnitine into the phospholipid bilayer leading to disruption of the vesicles. Palmitoyl carnitine at higher concentrations favours formation of multilamellar structures as is evident in figure 3 . The degree of incorporation of oleic acid increases with an increase in fatty acid concentration as seen in figure  4 . At 16PM, however, the vesicles are no longer markedly defined and an eventual breakdown of their vesicular structure is imminent. From our electron micrographs it appears as though incorporation of the cis-unsaturated fatty acid, oleic acid (concentrations of 12PM and below), causes conformational changes in ion channel proteins within the membrane. This inhibits the ion movements responsible for excitation in the normal myocardium. An alteration in membrane thickness could also accompany these changes. Higher concentrations of oleic acid increase Ca 2+ permeability of the SR and can disrupt the membrane structure (3).
The effects of exogenously added fatty acids on the Ca 2+ -ATPase observed in this study may occur because of (i) insertion into the bilayer, altering lipid-lipid and lipid-protein interactions, (ii) displacement of Ca 2+ ions from the negatively charged binding sites on the membrane phospholipid heads, (iii) interaction with an active site in the hydrophobic core of the enzyme, (iv) influence on ion permeability and (v) alteration of membrane fluidity. Amphiphilic compounds in high concentrations are well known in perturbing membrane structure, ion transport and ATPase activity in both sarcoplasmic reticulum and sarcolemmal membranes (10) . Our study demonstrated the wide disparities between the potencies of fatty acids with different chain lengths and degrees of saturation with respect to Ca 2+ -ATPase activity. At lower concentrations, palmitoyl carnitine is the most potent, followed by oleic acid while palmitic acid displays the least potency.
From this study it is evident that in vitro ischemic conditions have a detrimental effect on both the SR membrane and SR Ca 2+ -ATPase activity. However, this study encompasses the effect of only three fatty acids. In vivo, the amphiphilic compounds that accumulate in and around the myocardial cells during ischemia are structurally diverse and include fatty acids of variable chain and saturation as well as their carnitine and coenzyme A esters (10) . We conclude that the combined accumulation of these metabolites could produce an additive effect leading to cardiac mechanical dysfunction seen in the ischemic heart.
